SINGAPORE, July 29, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced construction has begun for a new ...
Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats. Finished building will be one ...
As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it's a strategic move in enabling their ...
The partnership will see Pharmadule Morimatsu deliver modular facilities for CDMO WuXi Biologics at its Singapore plant. Pharmadule, a company focused on delivering pharmaceutical manufacturing ...
Pharmadule Morimatsu to provide modular facilities for WuXi Biologics Singapore CRDMO Center project
WuXi Biologics (WuXi Bio), a leading global contract research, development, and manufacturing organization (CRDMO), announced a strategic partnership with Pharmadule Morimatsu, a diversified ...
SHANGHAI, June 27, 2023 /PRNewswire/ -- June 26 th, 2023, Pharmadule Morimatsu and WuXi Biologics officially entered into a global strategic cooperation for the Singapore CRDMO Center project of WuXi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results